New therapy offers hope in osteoporosis

A promising new treatment for osteoporosis significantly reduced fracture risk in women, according to trial results published this week.

The landmark study involved over 2000 postmenopausal women with osteoporosis and a high risk of fracture, who were randomised to daily injections of the experimental drug abaloparatide, a conventional osteoporosis drug teriparatide, or placebo.

Risk of a new vertebral fracture

Latest

Trending